Outlicensing Opportunities for New Partners. Veriton Pharma is seeking to enhance its corporate offering by way of gaining marketing authorisations for selected products.
Veriton Pharma are now looking to out-licence these products outside of their core UK market to interested partners.
Veriton Pharma is currently seeking potential partners with an interest in the CNS sector to market and distribute an epilepsy medication within the EEA and potentially RoW, outside the UK/Australia/MEA.
If you would be interested in taking one of our products and putting through the licensing program within your country please send us a message using the contact us form to discuss outlicensing opportunities further.
A Trusted Partner
We are always on the lookout for differentiated medicines and late-stage opportunities that could fit with our growing portfolio and can improve the standard of care for more patients around the world.